Adoneca H Fortier

Learn More
PURPOSE This study assessed the short-term and long-term efficacy of a presurgical stress management intervention at reducing mood disturbance and improving quality of life (QOL) in men undergoing radical prostatectomy (RP) for prostate cancer. PATIENTS AND METHODS One hundred fifty-nine men were randomly assigned to a two-session (plus two boosters)(More)
PURPOSE Previous research incorporating yoga (YG) into radiotherapy (XRT) for women with breast cancer finds improved quality of life (QOL). However, shortcomings in this research limit the findings. PATIENTS AND METHODS Patients with stages 0 to III breast cancer were recruited before starting XRT and were randomly assigned to YG (n = 53) or stretching(More)
Erythromycin, the standard treatment for chlamydial infection in pregnant women, commonly causes side-effects, which limits its efficacy. In a randomised, double-blind study, we compared amoxycillin with erythromycin in this setting. 210 pregnant women with Chlamydia trachomatis infection were randomly assigned 7 days' treatment with amoxycillin (500 mg(More)
Bendamustine, a cytotoxic alkylating agent, has shown promising results in solid tumors. An investigator-initiated phase I clinical trial of the anti-vascular endothelial growth factor agent bevacizumab and bendamustine was conducted in patients with advanced cancer, because the 2 drugs have different mechanisms of antitumor activity and nonoverlapping(More)
9009 Background: Radiotherapy (XRT) can decrease quality of life (QOL), disrupt cortisol rhythm and contribute to cardiovascular disease. We examined the effects of yoga on buffering changes in QOL, cortisol slope and heart rate variability (HRV) in women with breast cancer undergoing XRT. METHODS Patients with stage 0-III disease were recruited prior to(More)
BACKGROUND/AIMS We conducted a phase I trial of IP oxaliplatin and paclitaxel with IV paclitaxel and bevacizumab in patients with peritoneal carcinomatosis. METHODOLOGY Patients received IV bevacizumab (2.5mg/kg) over 1 hour (day 1), then IV paclitaxel (110 mg/m2) 24-hr-infusion (day 1) and IP oxaliplatin (25-40 mg/m2) (day 2), and IP paclitaxel (30-60(More)
Liver metastases in patients with cancer are associated with poor survival. We hypothesized that hepatic arterial infusion (HAI) of oxaliplatin combination therapy would have antitumor activity in these patients. Patients with advanced cancer and predominant liver metastases were treated on a phase I study of HAI oxaliplatin in combination with systemic(More)
Methods Patients with stage 0-III disease were recruited prior to XRT (baseline) and randomized to one of three groups: Yoga (YG-n=53) or Stretching program (STR-n=56) 3 times a week for 6 weeks during XRT or Waitlist Control (WLC-n=54). Self-report measures of fatigue (BFI), depression (CESD), QOL (SF-36), benefit finding (BF), and spirituality (FACT-SP)(More)
  • 1